44 results
8-K
EX-2.1
20tp0eu8hvy6g6w
24 Jul 23
Entry into a Material Definitive Agreement
7:16am
PRE 14A
sjhm5bbws16
4 Apr 23
Preliminary proxy
4:33pm
8-K
EX-99.1
q8qjz
1 Aug 22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
9:17am
424B5
zxgufyw4ewix36z0mzzi
19 May 22
Prospectus supplement for primary offering
4:44pm
8-K
EX-2.1
td199c llo
12 May 22
Entry into a Material Definitive Agreement
5:12pm
POS AM
fj31kcg30km1z1h
4 Mar 22
Prospectus update (post-effective amendment)
4:04pm